CABB, a global fine and specialty chemicals company, and a portfolio company of Bridgepoint Capital Group, has acquired KemFine Group from 3i Private Equity. Terms were not disclosed.
KemFine Group focuses on the custom manufacturing of fine chemicals for the global agro and pharma industries. It is headquartered in Helsinki and operates a production facility in Kokkola, Finland. CABB is one of the world leading suppliers of chemical building blocks based on chlorine and acetic acid and is the world market leader in monochloroacetic acid (MCAA), an essential component used in a wide range of applications ranging from herbicides and personal care to the food industry. It is also a leading custom manufacturer for global agrochemical, food, pharma and chemical companies.
CABB chief executive Dr. Martin Wienkenhver said: CABB will further strengthen its resilient position in many of its markets through this acquisition. We are very happy to have found with KemFine Group the right partner for the acceleration and further manifestation of our growth strategy.
Uwe Kolb, partner responsible for Bridgepoint investment activities in the German speaking countries, added: KemFine is a good fit with our recent acquisition of CABB and we are very pleased to be able to help the combined CABB and KemFine management teams to achieve their joint targets.
Ariel Levin, Partner at The Valence Group noted: This is our sixth transaction of 2011 and proves the extent to which our sector focus and expertise is valued in the chemicals M&A arena. Bridgepoint has skilfully managed to complete a complex back to back deal; our familiarity with the industry and business, including detailed product knowledge, was fundamental to their success. We look forward to continuing to deliver to our clients an unparalleled combination of skill sets and experience as they implement their M&A strategies.
Anton Ticktin, Director at The Valence Group said: This transaction demonstrated both our depth of understanding of the KemFine business and also our breadth of experience across fine chemicals, custom manufacturing and agrochemicals. KemFine is an outstanding company with more than 10 years of solid growth and, by combining CABB and KemFine, Bridgepoint will create a business with highly complementary customers, chemistries and technologies with the prospect of becoming an undisputed leader in its field. This acquisition demonstrates that The Valence Group sector experience extends across the entire chemicals chain and we are also especially proud to have contributed significant commercial and financial advisory support for the transaction.
Bridgepoint is a European private equity firm with offices throughout Europe in Frankfurt, Helsinki, Istanbul, London, Luxembourg, Madrid, Milan, Paris and Stockholm.
About The Valence Group
The Valence Group is a specialist M&A investment bank offering advisory services exclusively to companies and investors in the chemicals, materials and related sectors. The founders and senior members of The Valence Group have more than 250 years of collective transaction experience and have closed M&A transactions in over 100 different chemicals/materials subsectors. The Valence Group team includes a unique combination of professionals with backgrounds in investment banking, strategic consulting and senior management within the chemicals and materials industries. The firm’s offices are located in London, New York and Shanghai.